|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang YL, Zhang ZS, Wu BP and Zhou DY:
Early diagnosis for colorectal cancer in China. World J
Gastroenterol. 8:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andrews L: Dietary flavonoids for the
prevention of colorectal cancer. Clin J Oncol Nurs. 17:671–672.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Altobelli E, Lattanzi A, Paduano R,
Varassi G and di Orio F: Colorectal cancer prevention in Europe:
Burden of disease and status of screening programs. Prev Med.
62:132–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugarbaker PH: Colorectal cancer:
Prevention and management of metastatic disease. Biomed Res Int.
2014:7828902014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan DS, Lau R, Aune D, Vieira R,
Greenwood DC, Kampman E and Norat T: Red and processed meat and
colorectal cancer incidence: Meta-analysis of prospective studies.
PLoS One. 6:e204562011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lech G, Slotwinski R, Slodkowski M and
Krasnodebski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manfredi S, Lepage C, Hatem C, Coatmeur O,
Faivre J and Bouvier AM: Epidemiology and management of liver
metastases from colorectal cancer. Ann Surg. 244:254–259. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karp X and Ambros V: Developmental
biology. Encountering microRNAs in cell fate signaling. Science.
310:1288–1289. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Namlos HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One. 7:e480862012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pirola CJ, Gianotti TF, Castaño GO and
Sookoian S: Circulating MicroRNA-122 signature in nonalcoholic
fatty liver disease and cardiovascular disease: A new endocrine
system in metabolic syndrome. Hepatology. 57:2545–2547. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S, Wan X and Ruan Q: The MicroRNA-21
in autoimmune diseases. Int J Mol Sci. 17:E8642016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Witwer KW, Sarbanes SL, Liu J and Clements
JE: A plasma microRNA signature of acute lentiviral infection:
Biomarkers of central nervous system disease. AIDS. 25:2057–2067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lubezky N, Loewenstein S, Ben-Haim M,
Brazowski E, Marmor S, Pasmanik-Chor M, Oron-Karni V, Rechavi G,
Klausner JM and Lahat G: MicroRNA expression signatures in
intraductal papillary mucinous neoplasm of the pancreas. Surgery.
153:663–672. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-kappaB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abella V, Valladares M, Rodriguez T, Haz
M, Blanco M, Tarrio N, Iglesias P, Aparicio LA and Figueroa A:
miR-203 regulates cell proliferation through its influence on Hakai
expression. PLoS One. 7:e525682012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Huang H, Sun L, Yang M, Pan C, Chen
W, Wu D, Lin Z, Zeng C, Yao Y, et al: miR-21 indicates poor
prognosis in tongue squamous cell carcinomas as an apoptosis
inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang H, Tian H, Duan Z, Cao Y, Zhang XS
and Sun F: microRNA-383 impairs phosphorylation of H2AX by
targeting PNUTS and inducing cell cycle arrest in testicular
embryonal carcinoma cells. Cell Signal. 26:903–911. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han RL, Wang FP, Zhang PA, Zhou XY and Li
Y: miR-383 inhibits ovarian cancer cell proliferation, invasion and
aerobic glycolysis by targeting LDHA. Neoplasma. 64:244–252. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Azarbarzin S, Feizi MAH, Safaralizadeh R,
Kazemzadeh M and Fateh A: The value of miR-383, an Intronic miRNA,
as a diagnostic and prognostic biomarker in intestinal-type gastric
cancer. Biochem Genet. 55:244–252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Li Y, Liu Y, Xie P, Li F and Li G:
PAX6, a novel target of microRNA-7, promotes cellular proliferation
and invasion in human colorectal cancer cells. Dig Dis Sci.
59:598–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salem CE, Markl ID, Bender CM, Gonzales
FA, Jones PA and Liang G: PAX6 methylation and ectopic expression
in human tumor cells. Int J Cancer. 87:179–185. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Y, Wang L, Guo SC, Wu XB and Xu XH:
High-throughput sequencing to identify miRNA biomarkers in
colorectal cancer patients. Oncol Lett. 8:711–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang N, Lin J, Ruan J, Su N, Qing R, Liu
F, He B, Lv C, Zheng D and Luo R: miR-219-5p inhibits
hepatocellular carcinoma cell proliferation by targeting
glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sui GQ, Fei D, Guo F, Zhen X, Luo Q, Yin S
and Wang H: MicroRNA-338-3p inhibits thyroid cancer progression
through targeting AKT3. Am J Cancer Res. 7:1177–1187.
2017.PubMed/NCBI
|
|
31
|
Xu D, Ma P, Gao G, Gui Y, Niu X and Jin B:
MicroRNA-383 expression regulates proliferation, migration,
invasion and apoptosis in human glioma cells. Tumour Biol.
36:7743–7753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shang Y, Zang A, Li J, Jia Y, Li X, Zhang
L, Huo R, Yang J, Feng J, Ge K, et al: MicroRNA-383 is a tumor
suppressor and potential prognostic biomarker in human non-small
cell lung caner. Biomed Pharmacother. 83:1175–1181. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma H, Liu B, Wang S and Liu J:
MicroRNA-383 is a tumor suppressor in human lung cancer by
targeting endothelial PAS domain-containing protein 1. Cell Biochem
Funct. 34:613–619. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang Z, He L, Jia H, Huang Q, Chen D and
Zhang Z: The miR-383-LDHA axis regulates cell proliferation,
invasion and glycolysis in hepatocellular cancer. Iran J Basic Med
Sci. 20:187–192. 2017.PubMed/NCBI
|
|
35
|
Zhao LN, Wang P, Liu YH, Cai H, Ma J, Liu
LB, Xi Z, Li ZQ, Liu XB and Xue YX: miR-383 inhibits proliferation,
migration and angiogenesis of glioma-exposed endothelial cells in
vitro via VEGF-mediated FAK and Src signaling pathways. Cell
Signal. 30:142–153. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Z, Zeng X, Tian D, Xu H, Cai Q, Wang J
and Chen Q: MicroRNA-383 inhibits anchorage-independent growth and
induces cell cycle arrest of glioma cells by targeting CCND1.
Biochem Biophys Res Commun. 453:833–838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He Z, Cen D, Luo X, Li D, Li P, Liang L
and Meng Z: Downregulation of miR-383 promotes glioma cell invasion
by targeting insulin-like growth factor 1 receptor. Med Oncol.
30:5572013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li KK, Pang JC, Lau KM, Zhou L, Mao Y,
Wang Y, Poon WS and Ng HK: miR-383 is downregulated in
medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol.
23:413–425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamaoka T and Itakura M: Development of
pancreatic islets (Review). Int J Mol Med. 3:247–261.
1999.PubMed/NCBI
|
|
40
|
Elso C, Lu X, Weisner PA, Thompson HL,
Skinner A, Carver E and Stubbs L: A reciprocal translocation
dissects roles of Pax6 alternative promoters and upstream
regulatory elements in the development of pancreas, brain and eye.
Genesis. 51:630–646. 2013.PubMed/NCBI
|
|
41
|
Zhao Y, Lu G, Ke X, Lu X, Wang X, Li H,
Ren M and He S: miR-488 acts as a tumor suppressor gene in gastric
cancer. Tumour Biol. 37:8691–8698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Luo J, Li H and Zhang C: MicroRNA-7
inhibits the malignant phenotypes of nonsmall cell lung cancer in
vitro by targeting Pax6. Mol Med Rep. 12:5443–5448. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xia X, Yin W, Zhang X, Yu X, Wang C, Xu S,
Feng W and Yang H: PAX6 overexpression is associated with the poor
prognosis of invasive ductal breast cancer. Oncol Lett.
10:1501–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bai SW, Li B, Zhang H, Jonas JB, Zhao BW,
Shen L and Wang YC: Pax6 regulates proliferation and apoptosis of
human retinoblastoma cells. Invest Ophthalmol Vis Sci.
52:4560–4570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and
Wu LX: microRNA-223 promotes the growth and invasion of
glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep.
30:2263–2269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou YH, Hu Y, Mayes D, Siegel E, Kim JG,
Mathews MS, Hsu N, Eskander D, Yu O, Tromberg BJ and Linskey ME:
PAX6 suppression of glioma angiogenesis and the expression of
vascular endothelial growth factor A. J Neurooncol. 96:191–200.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Meng Y, Zou Q, Liu T, Cai X, Huang Y and
Pan J: microRNA-335 inhibits proliferation, cell-cycle progression,
colony formation and invasion via targeting PAX6 in breast cancer
cells. Mol Med Rep. 11:379–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
